Trials / Completed
CompletedNCT01087385
Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease
Troponin T as Risk Stratification Tool in Patients With Peripheral Arterial Occlusive Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- University Heart Center Freiburg - Bad Krozingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study hypothesis: elevated Troponin T is a marker of increased mortality in patients with peripheral arterial occlusive disease (PAOD).
Detailed description
Troponin T and I are established risk markers in patients with acute coronary syndrome. Only recently, troponin I was found to be elevated in patients with acute critical limb ischaemia. In another study, troponin I was associated with a higher mortality in patients with chronic critical limb ischaemia followed over two years. In a longitudinal study design we intend to follow all patients that were treated for symptomatic PAOD (Fontaine stages II-IV) from 01/2007 to 12/2007 in our department of angiology. Main outcome parameters are death and the occurrence of major vascular events and revascularization procedures during follow-up.
Conditions
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-03-16
- Last updated
- 2015-04-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01087385. Inclusion in this directory is not an endorsement.